For laboratory research use only · Not for human or veterinary use · 18+
Metabolic research

Buy SLU-PP-332 in Australia

Lyophilised powder, 5mg vial · Available to order, dispatched from Australia
$109.99

Buy SLU-PP-332 in Australia from Macropus Peptides as a 5mg research vial, priced and ready to order. SLU-PP-332 is a synthetic, non-steroidal small molecule that activates the three oestrogen-related receptors, ERR alpha, beta and gamma, with the greatest potency at ERR alpha. These orphan nuclear receptors control genes for mitochondrial biogenesis and oxidative metabolism, so the compound gives laboratories a direct chemical switch for that programme in cell and animal models. Each vial holds the compound as a dry solid, labelled with name, strength, lot number and storage temperature, and a certificate of analysis is available for every lot. Buying several vials in one order keeps a study on the same lot. Order online and your parcel is dispatched from within Australia to any Australian address. SLU-PP-332 is sold to adults aged 18 and over for in-vitro laboratory research only, not for human or veterinary use.

1
Frequently bought together
MOTS-C 10mg$99.99
For in-vitro laboratory research only. Not for human or veterinary use. Purchasers must be 18 or over.
CompoundSLU-PP-332
Amount5 mg
FormLyophilised powder
CategoryMetabolic research
Storage-20 °C, protect from light
TestingHPLC purity and mass spectrometry identity, every batch
Certificate of analysisAvailable for every lot, matched to the lot number on the label
Peptide calculator

SLU-PP-332 5mg vial

Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.

Vial content
5 mg
mg per mL2.50
mcg per mL2,500

Buy SLU-PP-332 Australia: 5mg Research Vial

Macropus Peptides supplies this ERR agonist as a 5mg vial at a fixed price, ready to order. Chemically it is a small organic molecule, yet it belongs in our metabolic range because so many studies run it next to mitochondrial and incretin peptides, and each vial is lot-released from one supply.

SLU-PP-332 Australia: what is SLU-PP-332

It is a synthetic, non-steroidal agonist of the oestrogen-related receptors, developed through medicinal chemistry on an earlier ERR ligand scaffold. The prefix reflects the university where the compound series was made. Structurally it is a compact aromatic acylhydrazone, and it is handled as an ordinary organic research compound: stored dry and dissolved in a suitable solvent before use, rather than reconstituted like a lyophilised peptide. It is purely preclinical, with no clinical development record.

SLU-PP-332 ERR agonist: nuclear receptor signalling

The oestrogen-related receptors ERR alpha, ERR beta and ERR gamma are orphan nuclear receptors. They carry the oestrogen name but bind no oestrogen, and no natural hormone ligand has been confirmed for them. They drive transcription of genes for mitochondrial biogenesis, fatty acid oxidation and oxidative phosphorylation, largely working with the coactivator PGC-1 alpha. The compound activates all three subtypes, most potently ERR alpha, which gives researchers one of very few direct chemical tools for switching this transcriptional programme on. It is used in skeletal muscle cells, hepatocytes and mouse models to study mitochondrial gene expression and respiration, and it pairs naturally with MOTS-C, which acts on energy sensing through AMPK instead.

SLU-PP-332 research: what the published studies show

Its pharmacology was characterised in ACS Chemical Biology in 2023, where it was tested in muscle cells and mice and its effect on oxidative gene expression was shown to depend on ERR alpha. A 2024 pharmacology paper in JPET examined it in diet-induced and genetic mouse models of metabolic syndrome, measuring glucose tolerance and energy expenditure. Both are preclinical studies, and both are summarised in our SLU-PP-332 research studies library.

SLU-PP-332 vial specifications

SpecificationDetail
CompoundSLU-PP-332
Amount5 mg
FormLyophilised powder
CategoryMetabolic research
Storage-20 °C, protect from light

A dry solid of the pan-ERR agonist sits under the crimped cap. Compound, 5mg content, lot and storage temperature are printed on the glass; forward the lot and its analysis certificate follows. Store the vial at -20 °C, protected from light and moisture.

SLU-PP-332 price in Australia

StrengthPricePrice per mg
SLU-PP-332 5mg$109.99$22.00 per mg

A single fixed price covers the 5mg vial; split it five ways for the per-milligram figure. Ordering two or more vials together is the usual way to extend a study without a lot change.

SLU-PP-332 5mg: where to buy in Australia

One vial supports reporter assays, gene expression panels and short culture experiments. Aromatic small molecules like this typically have limited solubility in water, so most protocols dissolve them first in an organic solvent such as DMSO and then dilute into media; follow the method your study specifies. Stock strengths:

  • 0.5 mL: 10 mg per mL
  • 1 mL: 5 mg per mL

Best place to buy SLU-PP-332 Australia

  • A priced 5mg vial of the pan-ERR agonist
  • Multi-vial orders drawn from one lot
  • Lot code printed on the vial, with its certificate
  • Stock in Australia, sent domestically without customs delay
  • Capsule, kit and trio formats of the compound also listed

SLU-PP-332 how to get: buy SLU-PP-332 online

  • Add the 5mg vial to your cart
  • Order enough vials to hold the study on one lot
  • Check the solvent your protocol names and add supplies
  • Pay, stating your age and research purpose
  • Keep the lot code and request its analysis certificate

SLU-PP-332 calculator: making a stock from 5mg

The calculator on the listing turns a solvent volume into milligram and microgram strengths. For this vial:

  • 0.5 mL: 10 mg per mL
  • 1 mL: 5 mg per mL
  • 2 mL: 2.5 mg per mL

Working concentrations in cell media are then set by further dilution from that stock. Solvents and consumables are in lab supplies, and the SLU-PP-332 starter kit adds bacteriostatic water, ten syringes and twenty swabs to one 5mg vial.

Is SLU-PP-332 available in Australia

It is available as a research compound only. The ERR agonist has no ARTG entry and has never won TGA approval. That keeps it out of human and animal use entirely; our buyers work with it in-vitro. Chemical scheduling is set by the Poisons Standard, which gets revised, so look up the present entry for your own organisation.

SLU-PP-332 for sale Australia wide

Orders are packed in Australia and dispatched to laboratories in each capital and in regional centres. The compound is also listed as SLU-PP-332 capsules, and it features with 5-Amino-1MQ and MOTS-C in the metabolic trio. Every other tool in the metabolic research range can join the same parcel.

References

  1. Synthetic ERRalpha/beta/gamma agonist induces an ERRalpha-dependent acute aerobic exercise response and enhances exercise capacity. ACS Chemical Biology. 2023.
  2. A synthetic ERR agonist alleviates metabolic syndrome. Journal of Pharmacology and Experimental Therapeutics. 2024.

Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.

Questions about SLU-PP-332 5mg

Chat on WhatsApp
SLU-PP-332 5mg$109.99